Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896832238> ?p ?o ?g. }
- W2896832238 endingPage "e50" @default.
- W2896832238 startingPage "e40" @default.
- W2896832238 abstract "This analysis of the global clinical antibacterial pipeline was done in support of the Global Action Plan on Antimicrobial Resistance. The study analysed to what extent antibacterial and antimycobacterial drugs for systemic human use as well as oral non-systemic antibacterial drugs for Clostridium difficile infections were active against pathogens included in the WHO priority pathogen list and their innovativeness measured by their absence of cross-resistance (new class, target, mode of action). As of July 1, 2018, 30 new chemical entity (NCE) antibacterial drugs, ten biologics, ten NCEs against Mycobacterium tuberculosis, and four NCEs against C difficile were identified. Of the 30 NCEs, 11 are expected to have some activity against at least one critical priority pathogen expressing carbapenem resistance. The clinical pipeline is dominated by derivatives of established classes and most development candidates display limited innovation. New antibacterial drugs without pre-existing cross-resistance are under-represented and are urgently needed, especially for geographical regions with high resistance rates among Gram-negative bacteria and M tuberculosis." @default.
- W2896832238 created "2018-10-26" @default.
- W2896832238 creator A5002172450 @default.
- W2896832238 creator A5011718546 @default.
- W2896832238 creator A5012643783 @default.
- W2896832238 creator A5013471493 @default.
- W2896832238 creator A5015749292 @default.
- W2896832238 creator A5021362018 @default.
- W2896832238 creator A5024862520 @default.
- W2896832238 creator A5028536003 @default.
- W2896832238 creator A5031454086 @default.
- W2896832238 creator A5037469107 @default.
- W2896832238 creator A5039260055 @default.
- W2896832238 creator A5052458295 @default.
- W2896832238 creator A5055642937 @default.
- W2896832238 creator A5073576936 @default.
- W2896832238 creator A5077051125 @default.
- W2896832238 date "2019-02-01" @default.
- W2896832238 modified "2023-10-12" @default.
- W2896832238 title "Analysis of the clinical antibacterial and antituberculosis pipeline" @default.
- W2896832238 cites W1594633721 @default.
- W2896832238 cites W1982983829 @default.
- W2896832238 cites W2045211463 @default.
- W2896832238 cites W2103125559 @default.
- W2896832238 cites W2139516496 @default.
- W2896832238 cites W2142343447 @default.
- W2896832238 cites W2149088130 @default.
- W2896832238 cites W2156687094 @default.
- W2896832238 cites W2239738725 @default.
- W2896832238 cites W2296093328 @default.
- W2896832238 cites W2298318901 @default.
- W2896832238 cites W2463990453 @default.
- W2896832238 cites W2520178085 @default.
- W2896832238 cites W2522806486 @default.
- W2896832238 cites W2551748872 @default.
- W2896832238 cites W2584184235 @default.
- W2896832238 cites W2588657365 @default.
- W2896832238 cites W2594914849 @default.
- W2896832238 cites W2599881574 @default.
- W2896832238 cites W2602667098 @default.
- W2896832238 cites W2603888074 @default.
- W2896832238 cites W2609957797 @default.
- W2896832238 cites W2618577729 @default.
- W2896832238 cites W2659039410 @default.
- W2896832238 cites W2736789977 @default.
- W2896832238 cites W2737095712 @default.
- W2896832238 cites W2766276781 @default.
- W2896832238 cites W2766785249 @default.
- W2896832238 cites W2769899821 @default.
- W2896832238 cites W2770431582 @default.
- W2896832238 cites W2774055322 @default.
- W2896832238 cites W2779019546 @default.
- W2896832238 cites W2789749219 @default.
- W2896832238 cites W2792154364 @default.
- W2896832238 cites W2793160008 @default.
- W2896832238 cites W2803333994 @default.
- W2896832238 cites W2806252171 @default.
- W2896832238 cites W2806430653 @default.
- W2896832238 cites W2807903540 @default.
- W2896832238 cites W2855253025 @default.
- W2896832238 cites W2896813584 @default.
- W2896832238 doi "https://doi.org/10.1016/s1473-3099(18)30513-9" @default.
- W2896832238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30337260" @default.
- W2896832238 hasPublicationYear "2019" @default.
- W2896832238 type Work @default.
- W2896832238 sameAs 2896832238 @default.
- W2896832238 citedByCount "140" @default.
- W2896832238 countsByYear W28968322382019 @default.
- W2896832238 countsByYear W28968322382020 @default.
- W2896832238 countsByYear W28968322382021 @default.
- W2896832238 countsByYear W28968322382022 @default.
- W2896832238 countsByYear W28968322382023 @default.
- W2896832238 crossrefType "journal-article" @default.
- W2896832238 hasAuthorship W2896832238A5002172450 @default.
- W2896832238 hasAuthorship W2896832238A5011718546 @default.
- W2896832238 hasAuthorship W2896832238A5012643783 @default.
- W2896832238 hasAuthorship W2896832238A5013471493 @default.
- W2896832238 hasAuthorship W2896832238A5015749292 @default.
- W2896832238 hasAuthorship W2896832238A5021362018 @default.
- W2896832238 hasAuthorship W2896832238A5024862520 @default.
- W2896832238 hasAuthorship W2896832238A5028536003 @default.
- W2896832238 hasAuthorship W2896832238A5031454086 @default.
- W2896832238 hasAuthorship W2896832238A5037469107 @default.
- W2896832238 hasAuthorship W2896832238A5039260055 @default.
- W2896832238 hasAuthorship W2896832238A5052458295 @default.
- W2896832238 hasAuthorship W2896832238A5055642937 @default.
- W2896832238 hasAuthorship W2896832238A5073576936 @default.
- W2896832238 hasAuthorship W2896832238A5077051125 @default.
- W2896832238 hasBestOaLocation W28968322382 @default.
- W2896832238 hasConcept C114851261 @default.
- W2896832238 hasConcept C142724271 @default.
- W2896832238 hasConcept C24527192 @default.
- W2896832238 hasConcept C2776460866 @default.
- W2896832238 hasConcept C2777975735 @default.
- W2896832238 hasConcept C2779685592 @default.
- W2896832238 hasConcept C2781069245 @default.
- W2896832238 hasConcept C4937899 @default.
- W2896832238 hasConcept C523546767 @default.